Physician profile
Michael Sosin
NPI 1346530656
$6,593.80
in general payments reported to CMS, 2019-2025
13 companies · $1,886 in 2025
The $1,886 reported for 2025 was more than what 82% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.08 · 2022: $1,948 · 2023: $481 · 2024: $2,226 · 2025: $1,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,753 · Travel and Lodging: $1,538 · Long Term Medical Supply Or Device Loan: $1,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,752.75 |
| Travel and Lodging | $1,537.84 |
| Long Term Medical Supply Or Device Loan | $1,303.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $2,112.63 | 2021-2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Surgical Innovation Associates, INC. | $1,500.00 | 2022 | |
| Integra Lifesciences Corporation | $1,432.30 | 2022-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $531.90 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Musculoskeletal Transplant Foundation INC. | $326.48 | 2022-2025 | |
| W. L. Gore & Associates, INC. | $317.59 | 2022 | |
| Kerecis Limited | $250.15 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $33.34 | 2023 | Collagenase Santyl, Regranex |
| Bioventus LLC | $26.06 | 2022 | |
| Convatec INC. | $19.50 | 2023 | |
| Celgene Corporation | $16.98 | 2023 | Zeposia |
| Paratek Pharmaceuticals, INC. | $13.89 | 2023 | Nuzyra |
| Allergan, INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sosin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.